Tolga Tanguler - 11 Nov 2024 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LXEO	Stock Option (right to buy)	Award	$0	+36,000		$0.000000	36,000	11 Nov 2024	Common Stock	36,000	$7.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option shall vest and become exercisable in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service.